Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.33 USD | -11.74% | -15.41% | -51.64% |
15/05 | Piper Sandler Cuts Akoya Biosciences Price Target to $6 From $8, Maintains Overweight Rating | MT |
14/05 | Top Midday Decliners | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-51.64% | 13Cr | |
+11.91% | 23TCr | |
+15.97% | 20TCr | |
+19.36% | 14TCr | |
+30.25% | 11TCr | |
+2.62% | 6.47TCr | |
+18.95% | 5.44TCr | |
+4.96% | 5.11TCr | |
+10.49% | 4.5TCr | |
+4.85% | 3.74TCr |
- Stock Market
- Equities
- AKYA Stock
- News Akoya Biosciences, Inc.
- UBS Adjusts Akoya Biosciences Price Target to $12 From $13, Maintains Buy Rating